Use of Perforated Barrier Membranes and IPRF Nano- Micro Sticky Bone

Bone Augmentation Clinical Trial

Official title:

The Use of Perforated Barrier Membranes and IPRF Nano- Micro Sticky Bone in Horizontal Alveolar Ridge Augmentation - Controlled Clinical and Histomorphometric Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04775940
• Other study ID #: FDASU-Rec ID021701
• Status: Completed
• Phase: N/A
• Start date: March 1, 2018
• Est. completion date: December 1, 2019

Study information

• Verified date: February 2021
• Source: Ain Shams University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Comparing amount of horizontal bone gain 4 months after alveolar ridge augmentation using IPRF Nano- micro Sticky Bone with perforated collagen membrane versus occlusive barrier membrane by : 1. clinical and Radiographic analysis . 2. Histomorphometric analysis .

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: December 1, 2019
• Est. primary completion date: September 1, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 20 Years to 40 Years

Eligibility

Inclusion Criteria:

1. Healthy adult patients.

2. Both sex, males and females. 3-Age from 20 - 40 years old. 4-All patients will be free from any systemic diseases as evidenced by Burkett's oral medicine health history questionnaire. 5-Remaining alveolar bone = 8mm vertically and = 4 mm horizontally. 6-Gingival biotype 1-2mm thickness.

Exclusion Criteria:

1. Smokers.

2. Pregnant and breast feeding females.

3. Mentally retarded Patients.

4. Presence of hematologic disease.

5. Previous radiation, chemotherapy, or immunosuppressive treatments.

6. Diabetes mellitus, metabolic bone disease, ongoing treatment with bisphosphonates drugs, or pregnancy.

7. Anticoagulant drugs, Endocarditis risk factors, renal and hepatic failure

Related Conditions & MeSH terms

• Bone Augmentation

Intervention

Procedure:
• Perforated collagen membrane
Horizontal Bone Augmentation using Perforated Collagen Membrane
• Occlusive collagen membrane
Occlusive collagen membrane

Locations

Country	Name	City	State
Egypt	Ain Shams University	Cairo

Sponsors (1)

Lead Sponsor	Collaborator
Ain Shams University

Country where clinical trial is conducted

Egypt, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Horizontal alveolar bone width in mm	Measured By Bone caliber and Cone Beam Computed Tomography (CBCT)	6 months